1.
Clinical characteristic | n (%) | |
Age (yr) | < 60 | 36 (78.3%) |
≥60 | 10 (21.7%) | |
Gender | Male | 34 (73.9%) |
Female | 12 (26.1%) | |
PS score | 0-1 | 39 (84.8%) |
2 | 7 (15.2%) | |
Histology | Adenocarcinoma | 33 (71.8%) |
Squamous cell carcinoma | 6 (13.0%) | |
Ad-sq carcinoma | 4 (8.7%) | |
Large cell carcinoma | 3 (6.5%) | |
Location of lung cancer | Peripheral type | 37 (80.4%) |
Central type | 9 (19.6%) | |
T stage | T1 | 12 (26.1%) |
T2 | 25 (54.3%) | |
T3 | 9 (19.6%) | |
Regional lymph node | N0 | 7 (15.2%) |
N1 | 26 (56.5%) | |
N2 | 13 (28.3%) | |
Site of brain metastases | Cerebrum | 38 (82.6%) |
Cerebellum | 8 (17.4%) | |
Metastatic symptoms | Yes | 35 (76.1%) |
No | 11 (23.9%) |